Cerebrovascular accidents in patients with a ventricular assist device

Journal of Thoracic and Cardiovascular Surgery

Volumn 134, Issue 1, 2007, Pages 114-123

  Tsukui, Hiroyuki ^a   Abla, Adib ^a   Teuteberg, Jeffrey J ^a   McNamara, Dennis M ^a   Mathier, Michael A ^a   Cadaret, Linda M ^a   Kormos, Robert L ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASSISTED CIRCULATION; BLOOD CELL COUNT; CEREBROVASCULAR ACCIDENT; CHILD; CONTROLLED STUDY; FEMALE; HISTORY OF MEDICINE; HUMAN; INFECTION PREVENTION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PREVENTION AND CONTROL; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; CHILD; FEMALE; HEART-ASSIST DEVICES; HEPARIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBOCYTOPENIA;

EID: 34250773485     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.02.044     Document Type: Article

References (27)

1. Deng M.C., Edwards L.B., Hertz M.I., Rowe A.W., Keck B.M., Kormos R., et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report-2005. J Heart Lung Transplant 24 (2005) 1182-1187
2. Schmid C., Weyand M., Nabavi D.G., Hammel D., Deng M.C., Ringelstein E.B., et al. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. Ann Thorac Surg 65 (1998) 1703-1710
3. Thomas C.E., Jichici D., Petrucci R., Urrutia V.C., and Schwartzman R.J. Neurologic complications of the Novacor left ventricular assist device. Ann Thorac Surg 72 (2001) 1311-1315
4. Bucerius J., Gummert J.F., Borger M.A., Walther T., Doll N., Onnasch J.F., et al. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg 75 (2003) 472-478
5. Almassi G.H., Sommers T., Moritz T.E., Shroyer A.L., London M.J., Henderson W.G., et al. Stroke in cardiac surgical patients: determinants and outcome. Ann Thorac Surg 68 (1999) 391-397 discussion 397-8
6. Hogue Jr. C.W., Murphy S.F., Schechtman K.B., and Davila-Roman V.G. Risk factors for early or delayed stroke after cardiac surgery. Circulation 100 (1999) 642-647
7. Tsukui H., Teuteberg J.J., Murali S., McNamara D.M., Buchanan J.R., Winowich S., et al. Biventricular assist device utilization for patients with morbid congestive heart failure: a justifiable strategy. Circulation 112 (2005) I65-I72
8. Lazar R.M., Shapiro P.A., Jaski B.E., Parides M.K., Bourge R.C., Watson J.T., et al. Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation 109 (2004) 2423-2427
9. El-Banayosy A., Arusoglu L., Kizner L., Tenderich G., Minami K., Inoue K., et al. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg 119 (2000) 581-587
10. Copeland III J.G., Smith R.G., Arabia F.A., Nolan P.E., Mehta V.K., McCarthy M.S., et al. Comparison of the CardioWest total artificial heart, the Novacor left ventricular assist system and the Thoratec ventricular assist system in bridge to transplantation. Ann Thorac Surg 71 (2001) S92-S97 discussion S114-5
11. Kalya A.V., Tector A.J., Crouch J.D., Downey F.X., McDonald M.L., Anderson A.J., et al. Comparison of Novacor and HeartMate vented electric left ventricular assist devices in a single institution. J Heart Lung Transplant 24 (2005) 1973-1975
12. Minami K., El-Banayosy A., Sezai A., Arusoglu L., Sarnowsky P., Fey O., et al. Morbidity and outcome after mechanical ventricular support using Thoratec, Novacor, and HeartMate for bridging to heart transplantation. Artif Organs 24 (2000) 421-426
13. Strauch J.T., Spielvogel D., Haldenwang P.L., Correa R.K., deAsla R.A., Seissler P.E., et al. Recent improvements in outcome with the Novacor left ventricular assist device. J Heart Lung Transplant 22 (2003) 674-680
14. Portner P.M., Jansen P.G., Oyer P.E., Wheeldon D.R., and Ramasamy N. Improved outcomes with an implantable left ventricular assist system: a multicenter study. Ann Thorac Surg 71 (2001) 205-209
15. Mussivand T., Hetzer R., Vitali E., Meyns B., Noirhomme P., Koerfer R., et al. Clinical results with an ePTFE inflow conduit for mechanical circulatory support. J Heart Lung Transplant 23 (2004) 1366-1370
16. Warkentin T.E., Sheppard J.A., Horsewood P., Simpson P.J., Moore J.C., and Kelton J.G. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96 (2000) 1703-1708
17. Tandler R., Weyand M., Schmid C., Gradaus R., Schmidt C., and Scheld H.H. Long-term anticoagulation with recombinant hirudin in a patient on left ventricular assist device support. Asaio J 46 (2000) 792-794
18. Christiansen S., Jahn U.R., Meyer J., Scheld H.H., Van Aken H., Kehrel B.E., et al. Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II. Ann Thorac Surg 69 (2000) 774-777
19. Di Napoli M., Papa F., and Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 32 (2001) 133-138
20. Grau A.J., Buggle F., Becher H., Werle E., and Hacke W. The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res 82 (1996) 245-255
21. Grau A.J., Buggle F., Becher H., Zimmermann E., Spiel M., Fent T., et al. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology 50 (1998) 196-203
22. Noto D., Barbagallo C.M., Cavera G., Cefalu A.B., Caimi G., Marino G., et al. Leukocyte count, diabetes mellitus and age are strong predictors of stroke in a rural population in southern Italy: an 8-year follow-up. Atherosclerosis 157 (2001) 225-231
23. Albert A.A., Beller C.J., Walter J.A., Arnrich B., Rosendahl U.P., Priss H., et al. Preoperative high leukocyte count: a novel risk factor for stroke after cardiac surgery. Ann Thorac Surg 75 (2003) 1550-1557
24. Ameriso S.F., Wong V.L., Quismorio Jr. F.P., and Fisher M. Immunohematologic characteristics of infection-associated cerebral infarction. Stroke 22 (1991) 1004-1009
25. Beamer N.B., Coull B.M., Clark W.M., Briley D.P., Wynn M., and Sexton G. Persistent inflammatory response in stroke survivors. Neurology 50 (1998) 1722-1728
26. Macko R.F., Ameriso S.F., Gruber A., Griffin J.H., Fernandez J.A., Barndt R., et al. Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke 27 (1996) 2005-2011
27. Hung T.C., Butter D.B., Yie C.L., Sun Z., Borovetz H.S., Kormos R.L., et al. Interim use of Jarvik-7 and Novacor artificial heart: blood rheology and transient ischemic attacks (TIAs). Biorheology 28 (1991) 9-25